FDA Drug Application (088482) for ANTABUSE by ODYSSEY PHARMS

Back to FDA Applications sponsored by ODYSSEY PHARMS

Application Number088482
Product Number001
FormTABLET;ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameANTABUSE
Active IngredientDISULFIRAM

Active IngredientCount
List of drugs with Active Ingredient DISULFIRAM2


Back to FDA Applications sponsored by ODYSSEY PHARMS